Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0649

+0.6%

Nov 13 3:42 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Khris Smith	8/12/2013 12:24:36 PM
	Read Replies (2) of 13111

Allovectin was pulled today. I guess this show how hard it is for small companies to succeed. One less competitor, and might explain why PVCT is taking so long to develop and start PIII? I would rather wait than fail. news.yahoo.com I have not read the PII study for Allovectin, but it appears odd that it could get through PII and fail so badly trying to hit it's PIII end points. How does that happen? Were they just guessing that it could shrink tumors? Update: They had 15 responders out 127 in the PII trial, with 4 having a CR or complete response. Salt water might have worked as well? Additionally, this PII trial was in 2003, and they just now, 10 years later have their PIII fail. Possibly some of the frustrations over delays at PVCT are misplaced when compared to a company like Vical?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next